SCHEMBL7572169

SCHEMBL7572169

O[C@H](COc1ccc(-c2occ3cc(F)ccc23)cc1)CN1CCOCC1

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.57
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 1/20 0.54
USP2 O75604 1/20 0.53
TSHR P16473 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
L3MBTL1 Q9Y468 3/20 0.52
MAPK1 P28482 3/20 0.52
GAA P10253 2/20 0.51
KMT2A Q03164 2/20 0.50
ABCB1 P08183 2/20 0.48
LMNA P02545 2/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1382258 0.91 ATM (0.56) KDM4ETSHRSMN1; SMN2KMT2AABCB1
SCHEMBL7572390 0.89 KDM4E (0.58) KDM4EALDH1A1USP2TSHRKMT2A
SCHEMBL7565949 0.87 KDM4E (0.51) PKMKDM4EALDH1A1USP2MAPK1
SCHEMBL1382380 0.86 DRD2 (0.53) USP2TSHRKMT2A
SCHEMBL7570879 0.86 DRD2 (0.53) USP2TSHRKMT2A
SCHEMBL1381988 0.85 CHRNA7 (0.49) PKMUSP2TSHR
SCHEMBL1383323 0.85 CHRNA7 (0.49) PKMUSP2TSHR
SCHEMBL7588884 0.82 ADRB3 (0.44) ALDH1A1TSHRSMN1; SMN2KMT2AABCB1
SCHEMBL7573958 0.82 CACNA1G (0.48) MAPK1KMT2ALMNA
SCHEMBL7569775 0.82 HTR1A (0.53) KDM4EALDH1A1USP2TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1216244-A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists Aventis Pharmaceuticals Inc. (US) 2002-06-26 EP disclosed
WO-2001019821-A1 BENZISOXAZOLYL-, PYRIDOISOXAZOLYL- AND BENZTHIENYL-PHENOXY DERIVATIVES USEFUL AS D4 ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2001-03-22 WO disclosed